No results for ‘’
Alfavision Overseas (India) Ltd
₹9.29
(1.42%)
Thu, 18 Jun 2026, 03:12 pm
Health Technology
Biotechnology
24.5KAlfavision Overseas (India) Price to Cash Flow Ratio
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 9.35 | 10.69 | 10.11 | 67.57 | 100 | 130.91 | 44.78 | 37.04 | 121.18 | 78.31 | 70.74 | 74.34 | 68.71 | 47.57 | 8.76 | 20.38 | 49.58 | 161.80 | 332.38 |
| Price to book ratio | 1.52 | 0.92 | 0.56 | 1.25 | 1.33 | 1.40 | 1.41 | 1.36 | 4.48 | 2.73 | 2.52 | 1.95 | 1.32 | 0.95 | 1.23 | 0.90 | 0.81 | 1.07 | 0.96 |
| Price to sales ratio | 3.78 | 1.97 | 0.68 | 1.28 | 2.31 | 1.59 | 0.38 | 0.25 | 0.67 | 0.65 | 0.62 | 0.16 | 0.09 | 0.05 | 0.07 | 0.23 | 1.10 | 14.30 | 21.22 |
| Price to cash flow ratio | 37.09 | 0 | 0 | 0 | 0 | 8.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 90.53 |
| Enterprise value | 7.84Cr | 5.54Cr | 5.09Cr | 9.39Cr | 11Cr | 10.72Cr | 12.62Cr | 12.72Cr | 36.09Cr | 22.57Cr | 24.94Cr | 41.52Cr | 41.62Cr | 60.17Cr | 70.28Cr | 183Cr | 159Cr | 169Cr | 165Cr |
| Enterprise value to EBITDA ratio | 10.58 | 11.20 | 21.40 | 0 | 0 | 0 | 228.81 | 116.09 | 164.80 | 88.42 | 41.46 | 21.40 | 17.27 | 17.95 | 17.51 | 37.08 | 69.62 | 176.20 | 1140 |
| Debt to equity ratio | 0 | 0.09 | 0.27 | 0.24 | 0.42 | 0.29 | 0.50 | 0.50 | 0.61 | 0.32 | 0.70 | 3.01 | 3.54 | 5.82 | 5.56 | 3.14 | 3 | 2.96 | 2.95 |
| Return on equity % | 0 | 8.55 | 5.70 | 1.89 | 1.32 | 1.09 | 3.22 | 3.75 | 3.78 | 3.56 | 3.64 | 2.70 | 1.94 | 2.01 | 15.16 | 7.26 | 1.56 | 0.65 | 0.29 |
Alfavision Overseas (India) Ltd Price to Cash Flow Ratio
The Alfavision Overseas (India) Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Alfavision Overseas (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Alfavision Overseas (India) Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alfavision Overseas (India) Ltd (NSE: , BSE: 531156) is currently trading at ₹9.29, with a market capitalization of ₹28.88Cr. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Alfavision Overseas (India) Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Alfavision Overseas (India) Ltd Price to Cash Flow Ratio Current Value
The current Alfavision Overseas (India) Ltd Price to Cash Flow Ratio stands at 90.53.
The latest Alfavision Overseas (India) Ltd Price to Cash Flow Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Alfavision Overseas (India) Ltd Price to Cash Flow Ratio Historical Trend
The Alfavision Overseas (India) Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 90.53
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The recent rise in Alfavision Overseas (India) Ltd Price to Cash Flow Ratio suggests strengthening valuation trends and improving market sentiment.
What Alfavision Overseas (India) Ltd Price to Cash Flow Ratio Indicates for Investors
The Alfavision Overseas (India) Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Alfavision Overseas (India) Ltd Price to Cash Flow Ratio Analysis Summary
The Alfavision Overseas (India) Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alfavision Overseas (India) Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alfavision Overseas (India) Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.